A blood-based host gene expression assay for early detection of respiratory viral infection: an index-cluster prospective cohort study.

dc.contributor.author

McClain, Micah T

dc.contributor.author

Constantine, Florica J

dc.contributor.author

Nicholson, Bradly P

dc.contributor.author

Nichols, Marshall

dc.contributor.author

Burke, Thomas W

dc.contributor.author

Henao, Ricardo

dc.contributor.author

Jones, Daphne C

dc.contributor.author

Hudson, Lori L

dc.contributor.author

Jaggers, L Brett

dc.contributor.author

Veldman, Timothy

dc.contributor.author

Mazur, Anna

dc.contributor.author

Park, Lawrence P

dc.contributor.author

Suchindran, Sunil

dc.contributor.author

Tsalik, Ephraim L

dc.contributor.author

Ginsburg, Geoffrey S

dc.contributor.author

Woods, Christopher W

dc.date.accessioned

2020-11-01T14:33:22Z

dc.date.available

2020-11-01T14:33:22Z

dc.date.issued

2020-09-24

dc.date.updated

2020-11-01T14:33:20Z

dc.description.abstract

BACKGROUND:Early and accurate identification of individuals with viral infections is crucial for clinical management and public health interventions. We aimed to assess the ability of transcriptomic biomarkers to identify naturally acquired respiratory viral infection before typical symptoms are present. METHODS:In this index-cluster study, we prospectively recruited a cohort of undergraduate students (aged 18-25 years) at Duke University (Durham, NC, USA) over a period of 5 academic years. To identify index cases, we monitored students for the entire academic year, for the presence and severity of eight symptoms of respiratory tract infection using a daily web-based survey, with symptoms rated on a scale of 0-4. Index cases were defined as individuals who reported a 6-point increase in cumulative daily symptom score. Suspected index cases were visited by study staff to confirm the presence of reported symptoms of illness and to collect biospecimen samples. We then identified clusters of close contacts of index cases (ie, individuals who lived in close proximity to index cases, close friends, and partners) who were presumed to be at increased risk of developing symptomatic respiratory tract infection while under observation. We monitored each close contact for 5 days for symptoms and viral shedding and measured transcriptomic responses at each timepoint each day using a blood-based 36-gene RT-PCR assay. FINDINGS:Between Sept 1, 2009, and April 10, 2015, we enrolled 1465 participants. Of 264 index cases with respiratory tract infection symptoms, 150 (57%) had a viral cause confirmed by RT-PCR. Of their 555 close contacts, 106 (19%) developed symptomatic respiratory tract infection with a proven viral cause during the observation window, of whom 60 (57%) had the same virus as their associated index case. Nine viruses were detected in total. The transcriptomic assay accurately predicted viral infection at the time of maximum symptom severity (mean area under the receiver operating characteristic curve [AUROC] 0·94 [95% CI 0·92-0·96]), as well as at 1 day (0·87 [95% CI 0·84-0·90]), 2 days (0·85 [0·82-0·88]), and 3 days (0·74 [0·71-0·77]) before peak illness, when symptoms were minimal or absent and 22 (62%) of 35 individuals, 25 (69%) of 36 individuals, and 24 (82%) of 29 individuals, respectively, had no detectable viral shedding. INTERPRETATION:Transcriptional biomarkers accurately predict and diagnose infection across diverse viral causes and stages of disease and thus might prove useful for guiding the administration of early effective therapy, quarantine decisions, and other clinical and public health interventions in the setting of endemic and pandemic infectious diseases. FUNDING:US Defense Advanced Research Projects Agency.

dc.identifier

S1473-3099(20)30486-2

dc.identifier.issn

1473-3099

dc.identifier.issn

1474-4457

dc.identifier.uri

https://hdl.handle.net/10161/21651

dc.language

eng

dc.publisher

Elsevier BV

dc.relation.ispartof

The Lancet. Infectious diseases

dc.relation.isversionof

10.1016/s1473-3099(20)30486-2

dc.title

A blood-based host gene expression assay for early detection of respiratory viral infection: an index-cluster prospective cohort study.

dc.type

Journal article

duke.contributor.orcid

Burke, Thomas W|0000-0003-0592-5822

duke.contributor.orcid

Henao, Ricardo|0000-0003-4980-845X

duke.contributor.orcid

Tsalik, Ephraim L|0000-0002-6417-2042

duke.contributor.orcid

Ginsburg, Geoffrey S|0000-0003-4739-9808

duke.contributor.orcid

Woods, Christopher W|0000-0001-7240-2453

pubs.organisational-group

School of Medicine

pubs.organisational-group

Nursing

pubs.organisational-group

Duke Cancer Institute

pubs.organisational-group

Pathology

pubs.organisational-group

Medicine, Cardiology

pubs.organisational-group

Duke

pubs.organisational-group

School of Nursing

pubs.organisational-group

Institutes and Centers

pubs.organisational-group

Clinical Science Departments

pubs.organisational-group

Medicine

pubs.organisational-group

Medicine, Infectious Diseases

pubs.organisational-group

Duke Global Health Institute

pubs.organisational-group

University Institutes and Centers

pubs.organisational-group

Institutes and Provost's Academic Units

pubs.organisational-group

Molecular Genetics and Microbiology

pubs.organisational-group

Basic Science Departments

pubs.publication-status

Published

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
A blood-based host gene expression assay for early detection of respiratory viral infection an index-cluster prospective coh.pdf
Size:
608.08 KB
Format:
Adobe Portable Document Format
Description:
Published version